Cytogenetic and dosimetric effects of 131I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments-Reference-Cited by-同舟云学术

Cytogenetic and dosimetric effects of 131I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments

Published:2016-03-24 Issue:3 Volume:55 Page:317-328
ISSN:0301-634X
Container-title:Radiation and Environmental Biophysics
language:en
Short-container-title:Radiat Environ Biophys

Author:

da Silva Márcia Augusta,Valgôde Flávia Gomes Silva,Gonzalez Júlia Armiliato,Yoriyaz Hélio,Guimarães Maria Inês Calil Cury,Ribela Maria Teresa Carvalho Pinto,Buchpiguel Carlos Alberto,Bartolini Paolo,Okazaki Kayo

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Subject

General Environmental Science,Radiation,Biophysics

Link

http://link.springer.com/content/pdf/10.1007/s00411-016-0646-5.pdf

Reference44 articles.

1. Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, Migliore L, Barale R (2002) Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat Res 514:77–85

2. Baugnet-Mahieu L, Lemaire M, Léonard ED, Léonard A, Gerber GB (1994) Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 140:429–431

3. Borget I, Remy H, Chevalier J, Ricard M, Allyn M, Schlumberger M, De Pouvourville G (2008) Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients:comparison between preparation with thyroid hormone withdrawal and thyrogen. Eur J Nucl Med Mol Imaging 35:1457–1463